Outcome of renal replacement therapy in ANCA-associated systemic vasculitis.

被引:0
|
作者
Allen, A [1 ]
Pusey, C [1 ]
Gaskin, G [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll, Sch Med, Div Med,Renal Sect, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2568 / 2568
页数:1
相关论文
共 50 条
  • [1] Histological and clinical predictors of renal outcome in ANCA-associated vasculitis.
    Neumann, I
    Kain, R
    Regele, H
    Soleiman, A
    Braun, C
    Meisl, FT
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 758A - 758A
  • [2] ANCA-associated vasculitis: Outcome and relapse on renal replacement therapy.
    Allen, A
    Pusey, CD
    Gaskin, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0388 - A0388
  • [3] Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.
    Jones, Rachel B.
    Tervaert, Jan Willem Cohen
    Hauser, Thomas
    Luqmani, Raashid
    Morgan, Matthew D.
    Peh, Chen Au
    Savage, Caroline O.
    Segelmark, Marten
    Tesar, Vladimir
    van Paassen, Pieter
    Walsh, Dorothy
    Walsh, Michael
    Westman, Kerstin
    Jayne, David R. W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03): : 211 - 220
  • [4] Renal involvement in ANCA-associated systemic vasculitis
    Van der Woude, FJ
    Ferrario, F
    D'Amico, G
    Imbasciati, E
    Roccatello, D
    Fornasieri, A
    Moriconi, L
    Radice, A
    Locatelli, F
    Bordin, G
    Montecucco, CM
    Gregorini, G
    Vendemia, F
    JOURNAL OF NEPHROLOGY, 1999, 12 (02) : 105 - 128
  • [5] Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
    Stone, John H.
    Merkel, Peter A.
    Spiera, Robert
    Seo, Philip
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Clair, E. William St.
    Turkiewicz, Anthony
    Tchao, Nadia K.
    Webber, Lisa
    Ding, Linna
    Sejismundo, Lourdes P.
    Mieras, Kathleen
    Weitzenkamp, David
    Ikle, David
    Seyfert-Margolis, Vicki
    Mueller, Mark
    Brunetta, Paul
    Allen, Nancy B.
    Fervenza, Fernando C.
    Geetha, Duvuru
    Keogh, Karina A.
    Kissin, Eugene Y.
    Monach, Paul A.
    Peikert, Tobias
    Stegeman, Coen
    Ytterberg, Steven R.
    Specks, Ulrich
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03): : 221 - 232
  • [6] Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis.
    Pagnoux, Christian
    Mahr, Alfred
    Hamidou, Mohamed A.
    Boffa, Jean-Jacques
    Ruivard, Marc
    Ducroix, Jean-Pierre
    Kyndt, Xavier
    Lifermann, Francois
    Papo, Thomas
    Lambert, Marc
    Le Noach, Jose
    Khellaf, Mehdi
    Merrien, Dominique
    Puechal, Xavier
    Vinzio, Stephane
    Cohen, Pascal
    Mouthon, Luc
    Cordier, Jean-Francois
    Guillevin, Loic
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (26): : 2790 - 2803
  • [7] Cyclosporine for the prevention of relapses in ANCA-associated vasculitis.
    Haubitz, M
    Koch, KM
    Brunkhorst, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0414 - A0414
  • [8] ANCA-associated vasculitis with renal involvement: an outcome analysis
    Weidner, S
    Geuss, S
    Hafezi-Rachti, S
    Wonka, A
    Rupprecht, HD
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (06) : 1403 - 1411
  • [9] Placebo-controlled trial of intravenous immunoglobulin in ANCA-associated systemic vasculitis.
    Jayne, D
    Chapel, H
    Adu, J
    O'Donoghue, D
    Misbah, S
    Scott, D
    Lockwood, CM
    KIDNEY INTERNATIONAL, 1999, 55 (06) : 2574 - 2574
  • [10] ANCA-associated renal vasculitis
    Savage, COS
    Harrington, JT
    Saville, J
    Rees, A
    Duffield, J
    Dillon, M
    Watson, A
    Powis, S
    Pusey, C
    Davison, A
    Iggo, N
    Reaich, D
    Roberts, I
    Mathieson, P
    Bone, J
    Stuart, L
    Gaskin, G
    Whitworth, C
    Ritz, E
    KIDNEY INTERNATIONAL, 2001, 60 (04) : 1614 - 1627